|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM234571489 |
003 |
DE-627 |
005 |
20250216135353.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2014 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2013.12.001
|2 doi
|
028 |
5 |
2 |
|a pubmed25n0781.xml
|
035 |
|
|
|a (DE-627)NLM234571489
|
035 |
|
|
|a (NLM)24434272
|
035 |
|
|
|a (PII)S1521-6616(13)00320-3
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Doi, Hiroyoshi
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis
|
264 |
|
1 |
|c 2014
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 08.04.2014
|
500 |
|
|
|a Date Revised 20.05.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Published by Elsevier Inc.
|
520 |
|
|
|a UNLABELLED: Hepatitis C cirrhosis is associated with a profound disappearance of memory B-cells. We sought to determine if this loss is associated with the expansion of the CD27(-)CD21(-) tissue-like memory B-cells with features of B-cell exhaustion. To this end, we quantified the frequency of CD27(-)CD21(-) B-cells in healthy, non-cirrhotic HCV-infected, and cirrhotic patients. We examined the expression of putative inhibitory receptors, the proliferative and immunoglobulin-secreting capacity of CD27/CD21-defined B-cell subsets upon B-cell receptor and/or CD40 stimulation. We found that CD27(-)CD21(-) B-cells are significantly increased in frequency relative to healthy donors in HCV-infected patients. CD27(-)CD21(-) B-cells were hypoproliferative relative to naïve and resting memory B-cells upon agonistic stimulation, but retained similar capacity for antibody secretion
|
520 |
|
|
|a CONCLUSION: CD27(-)CD21(-) tissue-like memory B-cells with exhausted proliferation circulate at increased frequency in cirrhotic and non-cirrhotic HCV-infected patients. This B-cell subset does not appear anergic, exhibiting immunoglobulin-secreting capacity on CD40 agonism indistinguishable from other CD27/CD21-defined B-cell subsets
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Anergy
|
650 |
|
4 |
|a B-cell
|
650 |
|
4 |
|a CD21
|
650 |
|
4 |
|a Hepatitis C
|
650 |
|
4 |
|a Human
|
650 |
|
4 |
|a Lymphocyte
|
650 |
|
7 |
|a Receptors, Antigen, B-Cell
|2 NLM
|
650 |
|
7 |
|a Receptors, Complement 3d
|2 NLM
|
650 |
|
7 |
|a Tumor Necrosis Factor Receptor Superfamily, Member 7
|2 NLM
|
700 |
1 |
|
|a Tanoue, Shiroh
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kaplan, David E
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 150(2014), 2 vom: 25. Feb., Seite 184-91
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:150
|g year:2014
|g number:2
|g day:25
|g month:02
|g pages:184-91
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2013.12.001
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 150
|j 2014
|e 2
|b 25
|c 02
|h 184-91
|